NGM282: a step forward in the nonalcoholic steatohepatitis treatment landscape?

Luca Valenti¹, Valerio Nobili^{2

3}

Affiliations

¹ Internal Medicine and Metabolic Diseases, Fondazione IRCCS Ca' Granda Ospedale Policlinico Milano, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
² Hepatology, Gastroenterology and Nutrition Unit, IRCCS "Bambino Gesù" Children's Hospital, Rome, Italy.
³ Department of Pediatric, University "La Sapienza", Rome, Italy.

Editorial

Luca Valenti et al. Hepatobiliary Surg Nutr. 2018 Dec.

. 2018 Dec;7(6):484-486.

doi: 10.21037/hbsn.2018.10.03.

Luca Valenti¹, Valerio Nobili^{2

3}

¹ Internal Medicine and Metabolic Diseases, Fondazione IRCCS Ca' Granda Ospedale Policlinico Milano, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
² Hepatology, Gastroenterology and Nutrition Unit, IRCCS "Bambino Gesù" Children's Hospital, Rome, Italy.
³ Department of Pediatric, University "La Sapienza", Rome, Italy.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Harrison SA, Rinella ME, Abdelmalek MF, Trotter JF, Paredes AH, Arnold HL, Kugelmas M, Bashir MR, Jaros MJ, Ling L, Rossi SJ, DePaoli AM, Loomba R. Harrison SA, et al. Lancet. 2018 Mar 24;391(10126):1174-1185. doi: 10.1016/S0140-6736(18)30474-4. Epub 2018 Mar 5. Lancet. 2018. PMID: 29519502 Clinical Trial.

1. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84. 10.1002/hep.28431 - DOI - PubMed
1. Estes C, Anstee QM, Teresa Arias-Loste M, et al. Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. J Hepatol 2018;69:896-904. 10.1016/j.jhep.2018.05.036 - DOI - PubMed
1. Nobili V, Svegliati-Baroni G, Alisi A, et al. A 360-Degree Overview Of Paediatric Nafld: Recent Insights. J Hepatol 2013;58:1218-29. 10.1016/j.jhep.2012.12.003 - DOI - PubMed
1. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010;52:1836-46. 10.1002/hep.24001 - DOI - PubMed
1. Dongiovanni P, Stender S, Pietrelli A, et al. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med 2018;283:356-70. 10.1111/joim.12719 - DOI - PMC - PubMed